Adoption of biologics in disease management and increasing regulatory approvals in the last few years, increasing scope of HPAPI market, patent expiration of major drugs, increasing trend of outsourcing, increase in the prevalence of chronic diseases...
The increase in diagnostic imaging procedures and interventional imaging procedures, increase in incidence and prevalence of disease conditions, increasing in aging population, expansion in indications of contrast media, growth of medical imaging tec...
. Some of the factors such as escalating prevalence of vascular or non-vascular stenotic conditions and cerebral aneurysms, elevating inclination towards minimally invasive therapeutic procedures across the globe, the trend of coronary stent price sl...
An increase in the adoption of minimally invasive surgeries, rapid growth in the aging population, growing number of cosmetic surgeries, the prevalence of obesity and its related surgeries, the advancement in technology, and demand for electrosurgica...
Some of the factors driving the market are increase in incidence and prevalence of osteoporosis, osteoarthritis, degenerative disc disease, herniated disc, scoliosis, kyphosis, lordosis, Ankylosing spondylitis, sacroiliac joint dysfunction, and, spor...
The rising incidence of infectious and non-infectious diseases and demand for early detection, diagnosis & treatment, increasing government and private funding, increasing advancements in cell imaging technologies to reduce the cost & time du...
The factors such as rising incidences of respiratory diseases, rapid growth in the geriatric population requiring long term ventilation, increase in the number of premature birth and the emergence of the COVID-19 pandemic are the factors driving the ...
The potential of AI to seamlessly assist and guide the healthcare personnel in arriving at the accurate, precise and rapid diagnostic or therapeutic conclusions, to improve patient care, to empower individuals in their self-care, to optimize the vari...
The factors driving the genomics market are demand for early disease detection, diagnosis, and treatment, rising government and private funding, increasing awareness and reduced cost of genomics test, favorable reimbursement, increasing demand for pe...
Some of the factors driving the market are increase in incidence and prevalence of neurovascular diseases like cerebral aneurysm, stroke, arteriovenous malformations, and increase in the aging population, technological advancement, acquisitions and f...
Technological advancements in cell line engineering (gene editing tools) & cell line development technologies, screening technologies and process development are giving immense growth opportunities for the market...
Factors like emergence of next generation biotherapeutics, development of personalized and orphan indication therapies and the persistently escalating prevalence of chronic, communicable and autoimmune diseases are expected to boost the market growth...